Mixed-reality games and apps make up a big chunk of the Meta Quest 3’s best content, turning your home into a boxing gym, a painter’s studio, the setting of an alien invasion, or pretty much anything ...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) will announce results for the second quarter of 2026 on Thursday, July 30, 2026. Company executives will review financial results ...

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) will announce results for the second quarter of 2026 on Thursday, July 30, 2026. Company executives will review financial results ...

Lithium packs with unbranded or low-cost BMS units are the highest risk according to the cybersecurity expert.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Edgewise Therapeutics has reported phase 2 data on its cardiomyopathy prospect, keeping the biotech on track to start pivotal development of a would-be challenger to Bristol Myers Squibb and ...

Reports suggest that the flaw lies in certain Bluetooth-enabled battery systems that allow nearby users to connect and shut ...

Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2024 Revenues for the Legacy Portfolio in the fourth quarter were $6.0 billion compared to $6.2 billion in the prior ...

Kardigan has sewn up its IPO plans, with the cardiovascular biotech expecting to bring in a cozy $320 million from its planned Nasdaq listing. The Bay Area company is planning to offer 23.3 million ...